EF
CSTL icon

Empowered Funds’s Castle Biosciences CSTL Stock Holding History

Empowered Funds’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.39M Buy
142,338
+10,154
+8% +$226K 0.02% 893
2026
Q1 		$3.25M Buy
132,184
+10,264
+8% +$336K 0.02% 845
2025
Q4 		$4.74M Buy
121,920
+23,740
+24% +$765K 0.08% 267
2025
Q3 		$2.24M Buy
98,180
+57,430
+141% +$1.17M 0.02% 866
2025
Q2 		$832K Buy
+40,750
New +$754K 0.01% 1145

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Empowered Funds's CSTL Position: Q2 2026 in Review

Empowered Funds increased its Castle Biosciences (CSTL) stake by 7.7% in Q2 2026, buying an estimated $226K and bringing the position to 142,338 shares worth $3.39M. The position accounts for 0.02% of the portfolio, ranked #893.

Empowered Funds first reported a position in CSTL in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.74M in Q4 2025. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Empowered Funds held 142,338 shares of Castle Biosciences worth $3.39M as of Q2 2026.
  • Empowered Funds bought 10,154 Castle Biosciences shares in Q2 2026, an estimated $226K.
  • Castle Biosciences made up 0.02% of Empowered Funds's portfolio in Q2 2026, its #893 holding.
  • Empowered Funds first reported a position in Castle Biosciences in Q2 2025 and has held it in 5 quarters since.
  • Empowered Funds's Castle Biosciences position peaked at $4.74M in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.